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Summary: Serum and plasma myoglobin and creatine kinase-MB catalytic activity were analysed in 157 patients
admitted within 2 hours of the onset of ehest pain (58 were retrospectively recognized s acute myocardial infarc-
tion).
Serum and plasma values were highly correlated for both myoglobin and creatine kinase-MB.
Plasma myoglobin appared to be more sensitive than creatine kinase-MB for the early diagnosis of acute myocardial
infarction; using a cut-off value of 100 μ§/1, 90% of acute myocardial infarction cases were correctly recognized
by plasma myoglobin 6 hours after the onset of ehest pain, with a diagnostic specificity of 100% for non-acute
myocardial infarction ehest pain subjects. Plasma creatine kinase-MB showed a diagnostic sensitivity of 62% and
a diagnostic specificity of 95% in the same group of patients.
We suggest the inclusion of the plasma myoglobin immunonephelometric assay together with plasma creatine
kinase-MB activity analysis in protocols for the early diagnosis of acute myocardial infarction.
Introduction our group first reported the very satisfactory correlation
0 , t · · , ι Λ. of this latter method with the radioimmunoassay (2, 10);Serum myoglobin is a very early marker of acute myo- . ,
 M . . „ , . . , .
. . . . "V . . . .. · , , thus, these alternative procedures have been used m
cardial miarction. even in patients without typical elec- „ , , , . , . „ .
,,. i · t ,Γν Λ r · i_ · i j· recent years for both acute myocardial infarction diag-trocardiographic changes (1). Van us authors, mcludmg " . ' . . * - ·, · · /, ,v ·,L /οΓ i_ t i. i nosis and mfarct size determmation (11), and more re-
our researeh group (2), have shown that serum myoglo^· , Λ . , , · ^ ^ · ^
* . ., \. ,. . "
 4 · j- i cently for the evaluation of coronary reperfiision afterbin provides an earher diagnosis of acute myocardial , " , . . , ,,„N
• f *· *u j *· i · x>r · thrombolytic therapy (12).infarction than does serum creatine kinase-MB iso- J r/ \ /
enzyme activity, which was pfeviously considered the JQ forther increase the rapidity of acute myocardial in-
biochemical "cornerstone" for acute myocardial infarc- faretion diagnosis in ehest pain subjects, we suggested
tion diagnosis (3).
 the assay Of plasma instead of serum myoglobin (13),
Until 4-5 years ago, however, the methods for serum since preliminary studies showed a high correlation be-
myoglobm assay were a radioimmunoassay (4) scarcely twe^n plasma and serum myoglobin immunonephelo-
suitable for an emergency laboratory, and the latex ag- nietric assays.
glutination method (5, 6), a semiquantitative procedure
 We report ^ ^ obtained oyer ft period Qf twQ yeafs
with an insatisfactory diagnostic sensitivity.
 for ^ eafly diagnosis Qf acute myocardia, infarction in
More recently, a turbidimetric assay (7) with excellent a group of non-selected ehest pain patients, using the
analytical performance (8) and a nephelometric assay measurement of plasma and serum myoglobin and the
(9) have been suggested for serum myoglobin assay, and assay of creatine kinase-MB activity.
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Materials and Methods
Paticnts
Wc studied 157 patients admitted within 2 hours from the onset of
ehest pain; 101 were males, aged between 33 and 72 (median 58)
and 56 were females (38 to 80 years, median 61). The studied
population was referred from the emergency cardiology department
of the tvvo major hospitals of our region, and includes only those
subjects with a high prediction of acute myocardial infarction.
Retrospectively, 58 patients (41 males and 17 females) were diag-
nosed s affected by aeute myocardial infarction according to the
World Health Organization criteria (14) based on clinical, electro-
cardiographic and enzymatic data; the results of myoglobin were
not provided to the physicians; 38 patients (66%) with acute myo-
cardial infarction received intravenous tlirombolytic therapy; the
others were not given the therapy, because of various contraindi-
cations.
Among non-acute myocardial infarction subjects, 28% were suffer-
ing from unstable angina pectoris, 23% from pneumonitis or pul^
monary embolism, 17% from pericarditis, 16% from gastric ulcer
or gastritis; for the remaining subjects there is no definite diag-
nosis. None of the patients had received intramuscular injections on
admission, and none had clinical fmdings of skeletal muscle injury.
For each patient, blood was sampled 3, 6, and 9 hours after the
onset of ehest pain, using both a lithium heparin vacutainer (Becton
Dickinson) and a vacutainer with no anticoagulant. The samples
were centrifuged (5 min at 2500 g) and processed for the analyses
of creatine kinase-MB and myoglobin.
Methods
Serum and plasma creatine kinase activity was analysed at 37 °C
on the Spectrum 2 analyser with reagents from Abbott (North
Chicago, IL) using the immunoinhibition procedure (Abbott) for
the estimation of creatine kinase-MB isoenzyme activity.
Serum and plasma myogiobin were analysed using the irnmunone-
phelometric (NA-Latex, Behringwerke, Marburg, Germany) me-
thod.
Tab. l Correlation (regression analysis, y = plasma; χ = serurn)
between serurn and plasma assays of myoglobin and creatine ki-
nase-MB (y = a + bx)
N Syx
Myoglobin
Creatine kinase-MB
(% of total
(creatirie kinase)
47 1.7
47 -0.11
0.973 0.982 1.037
1.002 Ό.969 0.096
Results
The correlation between serum and plasma values of
myoglobin and creatine kinase-MB was tested on 48
samples obtained from patients with acute myocardial
infarction; in both cases, the correlation was excellent
(tab. 1) for analytical values extending over a veiy
wide r nge.
The intra^day and between days imprecision of the me-
thods for myoglobin analysis (CV% =3.9 and 7.8 re-
spectively), and for creatine kinase activity estimation
(CV% = 5.1 and 8.9 respectively) indicates the low
variability of both the methods.
Tables 2 to 4 report the values for diagnostic sensitivity
and specificity and positive and negative predictivity of
plasma myoglobin and creatine kinase-MB in the dis-
crimination between acute myocardial infarction and
non-ac te myocardial infarction ehest pain patients,
tested 3, 6 and 9 hours from the onset of ehest pain.
The number of non-acute myocardial infarction control
patients gradually decreases; this is due to the percent-
age of subjects dismissed from the emergency cardi-
Tab. 2 Diagnostic performances of plasma creatine kinase-MB and myoglobin for acute myocardial
infarction diagnosis 3 hours after onset of ehest pain
Cut-off Diagnostic
sensitivity
Diagnostic
specificity
Positive
predictive value
Negative
predictive value
Youden
index
Creatine kinase-
MB
Myoglobin
5% of total
creatine kinase
100 μg/l
22%
38%
98%
100%
87%
100%
66%
71%
20
38
Tab. 3 Diagnostic performances of plasma creatine kinase-MB and myoglobin for acute myocardial
infarction diagnosis 6 hours after onset of ehest pain
Creatine kinase-
MB
Myoglobin
Cut-off
5% of total
creatine kinase
100 μg/l
Diagnostic
sensitivity
62%
90%
Diagnostic
specificity
94%
100%
Positive
predictive value
86%
100%
Negative
predictive value
81%
94%
Youden
index
56
90
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Tab. 4 Diagnostic performances of plasma creatine kinase-MB and myoglobin for acute myocardial
infarction diagnosis 9 hours after onset of ehest pain
Creatine kinase-
MB
Myoglobin
Cut-off
5% of total
creatine kinase
100 g/l
Diagnostic
sensitivity
97%
100%
Diagnostic
specificity
94%
100%
Positive
predictive value
95%
100%
Negative
predictive value
96%
100%
Youden
index
91
100
ology department after the exclusion of acute myocar-
dial infarction.
For myoglobin and creatine kinase-MB we used a cut-
off value of 100 g/l, and 5% of total enzyme activity,
respectively. These values had been previously calcu-
lated with the receiving operator characteristic curve
1
 analysis äs the best discriminating cut-off between acute
! myocardial infarction and non-acute myocardial infarc-
! tion ehest pain subjects (2), and are used routinely in
1
 our laboratory.
Plasma myoglobin appeared to be a more efficient bio-
chemical marker than creatine kinase-MB, being in-
creased in 90% of acute myocardial infarction patients
6 hours after the onset of ehest pain, with a diagnostic
specificity of 100% for non-acute myocardial infarction
t ehest pain patients.
Discussion
In recent years, the use of thrombplytic therapy has re-
duced myocardial damage and mortality in acute myo-
cardial infarction patients; however, such therapy must
be used during the first hours after the onset of myocar^
dial necrosis, thüs requiring a very early and specific
biochemical diagnosis, particularly in patients with un-
clear electrocardiographic data.
An early biochemical diagnosis of acute myocardial in-
farction cannot be based on sefum creatine kinase-MB
activity, since this marker peak§ too late during acute
myocardial infarction. Our data confirm that the release
of myoglobin in acute myocardial infarction patients is
an earlier event than creatine kinase-MB release, äs pre-
viously described on a large population (15); in fact,
40% and 90% of acute myocardial infarction patients
can be identified with the plasma myoglobin assay after
three and six hours frorn the onset of Symptoms, respeet-
ively, while the percentage of acute myocardial infarc-
tions identified with creatine kinase-MB activity assay
is significantly lower. These results are particularly
interesting, because electrocardiographic data are incon-
clusive for a certain percentage of acute myocardial in-
farction patients; in our population (data not shown),
the results of electrocardiography were inadequate for -a
conclusive diagnosis in about 10% of acute myocardial
infarction cases. In addition, the evaluation of myoglo-
bin has been reported äs a useful marker for evaluation
the myocardial reperfusion after thrombolytic therapy
(16).
Recently, Mair et al. (17) reported that the mass concen-
tration of creatine kinase-MB provides an earlier diag-
nosis of acute myocardial infarction than does its cata-
lytic concentration. Our preliminary results on a small
sample of acute myocardial infarction cases (data not
shown) confirm these results.
Our two-years experience has confirmed that the immu-
nonephelometric procedure for myoglobin analysis
makes an impörtant contribution to diagnosis. Evaluated
against classical quality control methods, the procedure
was shown to be precise and accurate. It is also rapid,
so that were able introduce the procedure into the labora-
tory routine äs an alternative to the previously used
radioimmunoassay method.
Cut-off values of 100 g/l for myoglobin and 5% of
total enzyme activity for creatine kinase-MB, previously
revealed by the receiver operating characteristic curve
analysis (2), gave the best discrimination of acute myo-
cardial infarction frorn non-acute myocardial infarction
ehest pain patients in our population; this cut-off, re-
cently confirmed by the group ofBakker (18), is slightly
higher than the Value of 90 g/l suggested by the pro-
ducer of the immunonephelometric kit for myoglobin
analysis, and which has been evaluated in a healthy con-
trol reference population. A higher cut-off value gives a
diagnostic specificity of 100% for discrimination of the
acute myocardial infarction group from non-acute myo-
cardial infarction patients. Also, during our two years
study, myoglobin values higher than 100 g/l were ob-
served in a small percentage of patients with skeletal
muscle injury (data not reported), but such diseases ra-
rely require a discrimination from acute myocardial in-
farction. However, when the ehest is accompanied by
clinically evident muscular damage, it should be borne
in mind that serum/plasma myoglobin or creatine kin-
ase-MB can also be released from skeletal muscle. In
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these cases, it is important to consider all the clinical,
electrocardiographic and laboratory data together, rather
than a single biochemical marker.
At the moment, myoglobin appears to be the most reli-
able biochemical marker for the early diagnosis of acute
myocardial infarction. Other approaches have been re-
cently suggested, such äs creatine kinase isoform analy-
sis (19), particularly the serum MM3/MM1 ratio, whose
alteration is a very early event in acute myocardial in-
farction patients. However, the use of this approach is
limited, since serum creatine kinase isoforms can only
be analysed by electrophoresis, isoelectric focusing and
liquid Chromatographie methods, which are inadequate
for a rapid routine analysis. The use of the immunolog-
ical procedure is still questionable, since the group of
Suzuki (20) described various monoclonal antibodies for
creatine kinase isoforms with different analytical speci-
ficities.
The other result of our study is the very high correlation
between serum and plasma myoglobin and creatine kin-
ase-MB, obtained in a large groüp of patients with va-
lues of the two analytes ranging over a wide ränge of
values. This result confirms our preliminary observation
(13) that the use of lithium heparin äs anticoagulant does
not affect the myoglobin and creatine kinase-MB immu-
nological assays, and does n,qt irihibit creatine kinase
enzyme activity. These data agree with another prelimi-
nary result from 10 acute myocardial infarction cases
(8) and with a study published by the gixmp ofMair (15)
which used a different anticoagulant.
The use of plasma instead of serum myoglobin is a use-
ful approach, reducing by about 20 minutes the time
required for a conclusive diagnosis of acute myocardial
infarction; in addition, the same sample can also be used
for creatine kinase-MB analysis.
We conclude that the nephelometric assay of plasma
myoglobin should be included, together with immunol-
ogical creatine kinase-MB analysis, äs a primary con-
tributory tool in the protocols for the diagnosis of acute
myocardial infarction in patients on their first day of ad-
mission.
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